A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour ...

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

Paul Ehrlich’s vision of a rational targeted strategy against invading microbes or malignant cells has been a driving research throughout the past century, bringing a scientific and therapeutic ...